REMEDIUM LIFECARE Financial Statement Analysis
|
||
The Revenues of REMEDIUM LIFECARE have increased by 1.00% YoY .
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has increased by 404.01 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
REMEDIUM LIFECARE Last 5 Annual Financial Results
[BOM: 539561]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹510 Cr | ₹505 Cr | ₹90 Cr | ₹2.89 Cr | ₹0.16 Cr |
Expenses | ₹503 Cr | ₹503 Cr | ₹89 Cr | ₹2.50 Cr | ₹0.23 Cr |
Operating Profit (Excl OI) | ₹7.17 Cr | ₹1.82 Cr | ₹0.72 Cr | ₹0.39 Cr | ₹-0.07 Cr |
Other Income | ₹0.83 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.09 Cr |
Interest | ₹0.45 Cr | ₹0.23 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.00 Cr |
Depreciation | ₹0.15 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.01 Cr | ₹0.00 Cr |
Profit Before Tax | ₹7.40 Cr | ₹1.53 Cr | ₹0.65 Cr | ₹0.38 Cr | ₹0.02 Cr |
Profit After Tax | ₹5.43 Cr | ₹1.08 Cr | ₹0.48 Cr | ₹0.28 Cr | ₹0.01 Cr |
Consolidated Net Profit | ₹5.43 Cr | ₹1.08 Cr | ₹0.48 Cr | ₹0.28 Cr | ₹0.01 Cr |
Earnings Per Share (Rs) | ₹15.07 | ₹2.99 | ₹1.33 | ₹0.77 | ₹0.02 |
PAT Margin (%) | 1.06 | 0.21 | 0.53 | 9.58 | 5.03 |
ROE(%) | 70.92 | 24.51 | 13.33 | 8.62 | 0.26 |
ROCE(%) | 102.54 | 18.16 | 7.39 | 11.16 | 0.62 |
Total Debt/Equity(x) | 0.00 | 0.00 | 2.72 | 0.11 | 0.02 |
Key Financials |
||
Market Cap | : | ₹ 812.4 Cr |
Revenue (TTM) | : | ₹ 2,708.8 Cr |
Net Profit(TTM) | : | ₹ 75.8 Cr |
EPS (TTM) | : | ₹ 7.5 |
P/E (TTM) | : | 10.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
REMEDIUM LIFECARE | -18.5% | -32% | 13.7% |
ADANI ENTERPRISES | 1.6% | -9.9% | 47.7% |
REDINGTON | 1.1% | -4.9% | 22.4% |
HONASA CONSUMER | -0.4% | 6.3% | NA |
MMTC | -2.1% | -8.4% | 126.7% |
MSTC | -1.8% | -11.1% | 165.9% |
LLOYDS ENTERPRISES | -4.8% | -2% | 299.8% |
VERITAS (INDIA) | -7.8% | 7.4% | 841.2% |
NOVARTIS INDIA | -2.1% | 0.1% | 70.7% |
REMEDIUM LIFECARE Revenues
[BOM: 539561]
Y-o-Y | 1.00 % |
5 Yr CAGR | 652.50 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹510 Cr | 1.00 | |
Mar2022 | ₹505 Cr | 460.67 | |
Mar2021 | ₹90 Cr | 3,015.36 | |
Mar2020 | ₹2.89 Cr | 1,717.61 | |
Mar2019 | ₹0.16 Cr | - |
REMEDIUM LIFECARE Operating Profit
[BOM: 539561]
Y-o-Y | 294.99 % |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹7.17 Cr | 294.99 | |
Mar2022 | ₹1.82 Cr | 151.04 | |
Mar2021 | ₹0.72 Cr | 86.34 | |
Mar2020 | ₹0.39 Cr | Positive | |
Mar2019 | ₹-0.07 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 291.67 % |
5 Yr CAGR | Positive |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 1.41% | 291.67 | |
Mar2022 | 0.36% | -55.00 | |
Mar2021 | 0.8% | -94.04 | |
Mar2020 | 13.43% | Positive | |
Mar2019 | -43.4% | - |
REMEDIUM LIFECARE Profit After Tax
[BOM: 539561]
Y-o-Y | 403.34 % |
5 Yr CAGR | 410.33 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹5.43 Cr | 403.34 | |
Mar2022 | ₹1.08 Cr | 124.12 | |
Mar2021 | ₹0.48 Cr | 73.65 | |
Mar2020 | ₹0.28 Cr | 3,362.50 | |
Mar2019 | ₹0.01 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 404.76 % |
5 Yr CAGR | -32.25 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 1.06 % | 404.76 | |
Mar2022 | 0.21 % | -60.38 | |
Mar2021 | 0.53 % | -94.47 | |
Mar2020 | 9.58 % | 90.46 | |
Mar2019 | 5.03 % | - |
REMEDIUM LIFECARE Earnings Per Share (EPS)
[BOM: 539561]
Y-o-Y | 404.01 % |
5 Yr CAGR | 423.93 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹15 | 404.01 | |
Mar2022 | ₹2.99 | 124.81 | |
Mar2021 | ₹1.33 | 72.73 | |
Mar2020 | ₹0.77 | 3,750.00 | |
Mar2019 | ₹0.02 | - |
REMEDIUM LIFECARE Return on Capital Employed (ROCE)
[BOM: 539561]
Y-o-Y | 464.65 % |
5 Yr CAGR | 258.61 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 102.54% | 464.65 | |
Mar2022 | 18.16% | 145.74 | |
Mar2021 | 7.39% | -33.78 | |
Mar2020 | 11.16% | 1,700.00 | |
Mar2019 | 0.62% | - |
REMEDIUM LIFECARE Share Price vs Sensex
Current Share Price | : | ₹80.6 |
Current MarketCap | : | ₹ 812.4 Cr |
Updated EOD on | : | May 14,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
REMEDIUM LIFECARE | -18.5% |
-32% |
13.7% |
SENSEX | -0.6% |
-2.1% |
18.4% |
REMEDIUM LIFECARE related INDICES
You may also like the below Video Courses
FAQ about REMEDIUM LIFECARE Financials
How the annual revenues of REMEDIUM LIFECARE have changed ?
The Revenues of REMEDIUM LIFECARE have increased by 1.00% YoY .
How the Earnings per Share (EPS) of REMEDIUM LIFECARE have changed?
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has increased by 404.01 % YoY .
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of REDINGTON LTD Intrinsic Value of HONASA CONSUMER LTD Intrinsic Value of MMTC LTD Intrinsic Value of MSTC LTD |
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs